Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.

Frank SJ, Johansen MJ, Martirosyan KS, Gagea M, Van Pelt CS, Borne A, Carmazzi Y, Madden T.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1024-30. doi: 10.1016/j.ijrobp.2012.09.007. Epub 2012 Oct 22.

2.

NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.

Morales FC, Hayashi Y, van Pelt CS, Georgescu MM.

Cell Death Dis. 2012 Sep 20;3:e391. doi: 10.1038/cddis.2012.131.

3.

Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.

You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, Liang D, Wei W, Sood AK, Li C.

J Control Release. 2012 Mar 10;158(2):319-28. doi: 10.1016/j.jconrel.2011.10.028. Epub 2011 Oct 28.

4.

Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.

Gupta S, Wright KC, Ensor J, Van Pelt CS, Dixon KA, Kundra V.

Cardiovasc Intervent Radiol. 2011 Oct;34(5):1021-30. doi: 10.1007/s00270-011-0154-6. Epub 2011 Apr 9.

5.

Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.

Kim WY, Kim MJ, Moon H, Yuan P, Kim JS, Woo JK, Zhang G, Suh YA, Feng L, Behrens C, Van Pelt CS, Kang H, Lee JJ, Hong WK, Wistuba II, Lee HY.

Endocrinology. 2011 Jun;152(6):2164-73. doi: 10.1210/en.2010-0693. Epub 2011 Mar 29.

6.

Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.

Akli S, Van Pelt CS, Bui T, Meijer L, Keyomarsi K.

Cancer Res. 2011 May 1;71(9):3377-86. doi: 10.1158/0008-5472.CAN-10-4086. Epub 2011 Mar 8.

7.

Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Xiong S, Pant V, Suh YA, Van Pelt CS, Wang Y, Valentin-Vega YA, Post SM, Lozano G.

Cancer Res. 2010 Sep 15;70(18):7148-54. doi: 10.1158/0008-5472.CAN-10-1457. Epub 2010 Aug 24.

8.

Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.

Deng J, Fujimoto J, Ye XF, Men TY, Van Pelt CS, Chen YL, Lin XF, Kadara H, Tao Q, Lotan D, Lotan R.

Cancer Prev Res (Phila). 2010 Apr;3(4):424-37. doi: 10.1158/1940-6207.CAPR-10-0032. Epub 2010 Mar 30.

9.

Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.

Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt CS, Nakamura H, Leask A, Abraham D, Bou-Gharios G, de Crombrugghe B.

Arthritis Rheum. 2010 May;62(5):1523-32. doi: 10.1002/art.27382.

10.

The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.

Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G.

Genes Dev. 2008 May 15;22(10):1337-44. doi: 10.1101/gad.1662908.

11.

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82. Epub 2007 Nov 13.

PMID:
18000218
12.

Mtbp haploinsufficiency in mice increases tumor metastasis.

Iwakuma T, Tochigi Y, Van Pelt CS, Caldwell LC, Terzian T, Parant JM, Chau GP, Koch JG, Eischen CM, Lozano G.

Oncogene. 2008 Mar 20;27(13):1813-20. Epub 2007 Oct 1.

PMID:
17906694
13.

The p53-Mdm2 network in progenitor cell expansion during mouse postnatal development.

Liu G, Terzian T, Xiong S, Van Pelt CS, Audiffred A, Box NF, Lozano G.

J Pathol. 2007 Dec;213(4):360-8.

PMID:
17893884
14.

Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.

Akli S, Van Pelt CS, Bui T, Multani AS, Chang S, Johnson D, Tucker S, Keyomarsi K.

Cancer Res. 2007 Aug 1;67(15):7212-22.

15.

Loss of Mdm4 results in p53-dependent dilated cardiomyopathy.

Xiong S, Van Pelt CS, Elizondo-Fraire AC, Fernandez-Garcia B, Lozano G.

Circulation. 2007 Jun 12;115(23):2925-30. Epub 2007 May 28.

PMID:
17533180
16.

Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.

Terzian T, Wang Y, Van Pelt CS, Box NF, Travis EL, Lozano G.

Mol Cell Biol. 2007 Aug;27(15):5479-85. Epub 2007 May 25.

17.
18.

Impaired angiogenesis in aminopeptidase N-null mice.

Rangel R, Sun Y, Guzman-Rojas L, Ozawa MG, Sun J, Giordano RJ, Van Pelt CS, Tinkey PT, Behringer RR, Sidman RL, Arap W, Pasqualini R.

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4588-93. Epub 2007 Mar 7.

19.

The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.

Liu Y, Zhang W, Cheung LH, Niu T, Wu Q, Li C, Van Pelt CS, Rosenblum MG.

Neoplasia. 2006 May;8(5):384-93.

20.

Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Xiong S, Van Pelt CS, Elizondo-Fraire AC, Liu G, Lozano G.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3226-31. Epub 2006 Feb 21.

21.

Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.

Wright KC, Yang P, Van Pelt CS, Hicks ME, Collin P, Newman RA.

J Exp Ther Oncol. 2005;5(1):55-68.

PMID:
16416602
22.
23.

Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.

Lee HY, Oh SH, Woo JK, Kim WY, Van Pelt CS, Price RE, Cody D, Tran H, Pezzuto JM, Moriarty RM, Hong WK.

J Natl Cancer Inst. 2005 Nov 16;97(22):1695-9.

PMID:
16288123
24.

Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3.

Peleg S, Khan F, Navone NM, Cody DD, Johnson EM, Van Pelt CS, Posner GH.

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):203-11. Epub 2005 Aug 2.

PMID:
16081281
25.

Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression.

Klein RD, Van Pelt CS, Sabichi AL, Dela Cerda J, Fischer SM, Fürstenberger G, Müller-Decker K.

Cancer Res. 2005 Mar 1;65(5):1808-13.

26.

Ethiodized oil-ethanol capillary embolization in rabbit kidneys: temporal histopathologic findings.

Kónya A, Van Pelt CS, Wright KC.

Radiology. 2004 Jul;232(1):147-53.

PMID:
15220499
27.

Role of prolactin in chloro-S-triazine rat mammary tumorigenesis.

O'Connor JC, Plowchalk DR, Van Pelt CS, Davis LG, Cook JC.

Drug Chem Toxicol. 2000 Nov;23(4):575-601.

PMID:
11071396
28.

Chronic toxicity and oncogenicity bioassay in rats with the chloro-s-triazine herbicide cyanazine.

Bogdanffy MS, O'Connor JC, Hansen JF, Gaddamidi V, Van Pelt CS, Green JW, Cook JC.

J Toxicol Environ Health A. 2000 Aug 25;60(8):567-86.

PMID:
10983523
29.

90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17 beta-estradiol.

Biegel LB, Flaws JA, Hirshfield AN, O'Connor JC, Elliott GS, Ladics GS, Silbergeld EK, Van Pelt CS, Hurtt ME, Cook JC, Frame SR.

Toxicol Sci. 1998 Aug;44(2):116-42.

PMID:
9742652
30.

Weak estrogenic activity from continuous-release pellets.

O'Connor JC, Cook JC, Van Pelt CS, Arnold SF, Obourn JD.

Reprod Toxicol. 1997 Jan-Feb;11(1):101-6.

PMID:
9138628
31.

An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators.

O'Connor JC, Cook JC, Craven SC, Van Pelt CS, Obourn JD.

Fundam Appl Toxicol. 1996 Oct;33(2):182-95.

PMID:
8921337
32.

Hepatic and adrenal changes in rabbits associated with hyperlipidemia caused by a semi-synthetic diet.

Hausner EA, Schlingmann KL, Chen HW, Gillies PJ, Kieras CJ, Ross PE, Van Pelt CS.

Lab Anim Sci. 1995 Dec;45(6):663-70.

PMID:
8746527
33.

Modulation of rat hepatic cytochromes P450 by chronic methapyrilene treatment.

Wrighton SA, VandenBranden M, Brown TJ, Van Pelt CS, Thomas PE, Shipley LA.

Biochem Pharmacol. 1991 Aug 8;42(5):1093-7.

PMID:
1872894
34.

Catecholamine-synthesizing enzymes and chromogranin proteins in drug-induced proliferative lesions of the rat adrenal medulla.

Tischler AS, Ruzicka LA, Van Pelt CS, Sandusky GE.

Lab Invest. 1990 Jul;63(1):44-51.

PMID:
1695697
36.

An immunocytochemical study of pituitary adenomas and focal hyperplasia in old Sprague-Dawley and Fischer 344 rats.

Sandusky GE, Van Pelt CS, Todd GC, Wightman K.

Toxicol Pathol. 1988;16(3):376-80.

PMID:
3194659

Supplemental Content

Loading ...
Support Center